Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Gastrointestinal Stromal Tumors
Both
Gastrointestinal Stromal Tumors
Trial Information
Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting
Inclusion Criteria:
- Patients diagnosed with GIST based on ICD-9 code from January 2005 to present will be
eligible. This will include current active patients as well as patients who have
expired and have medical chart available.
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Retrospective
Principal Investigator
Jeffrey F Patton, M.D.
Investigator Role:
Study Chair
Investigator Affiliation:
Sarah Cannon Research Institute
Authority:
United States: Institutional Review Board
Study ID:
SCRI OUTCOMES 01
NCT ID:
NCT00877045
Start Date:
January 2008
Completion Date:
February 2009
Related Keywords:
- Gastrointestinal Stromal Tumors
- Gastrointestinal Stromal Tumors
- GIST
- tyrosine kinase inhibitors
- Imatinib
- Gleevec
- Suntinib
- Sutent
- Gastrointestinal Stromal Tumors
Name | Location |
|---|---|
| Georgia Cancer Specialists | Decatur, Georgia 30033 |
| Florida Cancer Specialists | Fort Myers, Florida 33901 |
| Virginia Cancer Institute | Richmond, Virginia 23230 |
| Tennessee Oncology, PLLC | Clarksville, Tennessee 37043 |
| Chattanooga Oncology Hematology Associates | Chattanooga, Tennessee 37404 |
